Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Perceptive Advisors Llc
Form 13F · Q2 2026

Perceptive Advisors Llc

CIK 1224962申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$66.6亿
申报组合市值
109
持仓数量
12
Quarters on record
Top 50
持仓数量

Perceptive Advisors Llc——持仓

共 109 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1PRAX Praxis Precision Medicines I2.0M+0.0%$6.8亿10.2%
2SYRE Spyre Therapeutics Inc4.3M+14.2%$3.8亿5.8%
3CELC Celcuity Inc3.2M+2.2%$3.3亿5.0%
4ASND Ascendis Pharma A/S1.2M—$3.1亿4.7%
5RYTM Rhythm Pharmaceuticals Inc2.6M+9.0%$2.9亿4.3%
6ROIV Roivant Sciences Ltd8.1M−2.4%$2.9亿4.3%
7RLAY Relay Therapeutics Inc14.1M+44.7%$2.6亿4.0%
8TVTX Travere Therapeutics Inc3.8M−9.4%$2.1亿3.2%
9KARD Kardigan Inc8.2M—$2.0亿2.9%
10NUVALENT INC Nuvalent Inc1.6M+0.0%$2.0亿2.9%
11EWTX Edgewise Therapeutics Inc4.4M−1.1%$1.8亿2.7%
12APOGEE THERAPEUTICS INC Apogee Therapeutics Inc1.3M−15.1%$1.7亿2.6%
13AMLX Amylyx Pharmaceuticals Inc8.3M+0.6%$1.5亿2.2%
14MGTX Meiragtx Hldgs Plc10.8M+4.5%$1.5亿2.2%
15ORKA Oruka Therapeutics Inc1.3M−3.6%$1.3亿1.9%
16INBX Inhibrx Biosciences Inc1.3M−10.0%$1.2亿1.8%
17PTGX Protagonist Therapeutics Inc981,879−20.2%$1.2亿1.8%
18SLDB Solid Biosciences Inc11.9M+0.0%$1.2亿1.8%
19ZYME Zymeworks Inc4.2M+19.2%$1.1亿1.6%
20TNGX Tango Therapeutics Inc3.4M+317.9%$1.1亿1.6%
21IMTX Immatics N.V10.4M+0.0%$1.1亿1.6%
22NRIX Nurix Therapeutics Inc4.3M+16.4%$1.0亿1.6%
23BCRX Biocryst Pharmaceuticals Inc10.3M+38.7%$1.0亿1.5%
24RVMD Revolution Medicines Inc527,600+104.0%$9881万1.5%
25AVLN Avalyn Pharmaceuticals Inc2.7M—$8807万1.3%
26DYN Dyne Therapeutics Inc2.7M−42.4%$5973万0.9%
27BIIB Biogen Inc276,173—$5967万0.9%
28IMVT Immunovant Inc1.4M−15.0%$5230万0.8%
29UNH Unitedhealth Group Inc116,806—$4855万0.7%
30IONS Ionis Pharmaceuticals Inc566,000+12.3%$4488万0.7%
31STRO Sutro Biopharma Inc1.3M+82.4%$4332万0.7%
32ANRO Alto Neuroscience Inc1.6M−19.9%$4249万0.6%
33JAZZ Jazz Pharmaceuticals Plc170,000+0.0%$4096万0.6%
34CRVS Corvus Pharmaceuticals Inc2.7M+16.4%$3985万0.6%
35SION Sionna Therapeutics Inc905,000+37.4%$3981万0.6%
36CTMX Cytomx Therapeutics Inc.10.4M+3.4%$3915万0.6%
37AORT Artivion Inc1.7M+6.1%$3904万0.6%
38XFOR X4 Pharmaceuticals Inc7.9M+17.7%$3705万0.6%
39CORT Corcept Therapeutics Inc398,385+696.8%$3464万0.5%
40RGEN Repligen Corp248,212−11.5%$3387万0.5%
41AVR Anteris Technologies Global3.4M+0.0%$3374万0.5%
42RAPP Rapport Therapeutics Inc773,342+14.8%$3223万0.5%
43DMRA Damora Therapeutics Inc1.2M+0.0%$3181万0.5%
44CRL Charles Riv Labs Intl Inc140,000—$3175万0.5%
45AXSM Axsome Therapeutics Inc.118,450−21.0%$2899万0.4%
46DBVT Dbv Technologies S A1.7M+71.4%$2711万0.4%
47IRTC Irhythm Holdings Inc223,766+113.1%$2662万0.4%
48ADPT Adaptive Biotechnologies Cor1.2M+698.2%$2611万0.4%
49SABS Sab Biotherapeutics Inc6.6M+3.0%$2585万0.4%
50DHR Danaher Corp Del130,000—$2476万0.4%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。